Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside

23 Oct 2024

Abstract excerpt

BACKGROUND: Gastrointestinal (GI) cancers represent a significant health burden worldwide. Their incidence continues to increase, and their management remains a clinical challenge. Chimeric antigen receptor (CAR) natural killer (NK) cells have emerged as a promising alternative to CAR-T cells for immunotherapy of GI cancers. Notably, CAR-NK cells offer several advantages, including reduced risk of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39443938
DOI: 10.1186/s12943-024-02151-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedsidePMID 39443938Read ↗

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challengesSemantic proximity Read ↗

A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?Semantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: a new force in intrinsic immunotherapy for cancer treatmentSemantic proximity Read ↗

Advantages and clinical applications of natural killer cells in cancer immunotherapy.Semantic proximity Read ↗

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful DevelopmentSemantic proximity Read ↗

NKT cells - New players in CAR cell immunotherapy?Semantic proximity Read ↗

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the futureSemantic proximity Read ↗

CAR-NK cell therapy: a potential antiviral platformSemantic proximity Read ↗

Cytotoxic CD8+ T cells in cancer and cancer immunotherapySemantic proximity Read ↗

Application and prospects of genetic engineering in CAR-NK cell therapySemantic proximity Read ↗

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Semantic proximity Read ↗

Current status and perspective of CAR-T and CAR-NK cell therapy trials in GermanySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.